
- Volume 0 0
Azithromycin for Injection
AmericanPharmaceuticalPartners(Schaumburg,Ill) recently receivedFDA approvalfor its abbreviatednew drug applicationfor Azithromycin forInjection. The product is the genericequivalent of Pfizer Inc's Zithromax.Azithromycin for Injection is indicated forthe treatment of community-acquiredpneumonia and pelvic inflammatory disease,when caused by susceptiblemicroorganisms. The product will beavailable in 500-mg vials. Azithromycinfor Injection is preservative-free, andeach vial will include a bar code andlatex-free vial stopper. For more information,visit www.appdrugs.com.
Articles in this issue
over 19 years ago
British Poll Shows People Denying Weight Problemsover 19 years ago
Suing a Lawyer for Malpractice?over 19 years ago
Pharmacists—Cops or Not? (Part 1)over 19 years ago
Can You Read These Rxs?over 19 years ago
Alternative Measures for Treating Pediculosisover 19 years ago
Compounding Hotlineover 19 years ago
Obesity May Lead to Kidney Failureover 19 years ago
Body Fat Associated with Alzheimer's Proteinover 19 years ago
Midlife Obesity May Cause Heart Diseaseover 19 years ago
The Evolution of Imprint IdentificationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.